Complete Response Induced by Concurrent Chemoradiotherapy in a Patient with NUT Carcinoma

An 18-year-old man presented with sudden vision loss in his left eye. Magnetic resonance imaging revealed a tumor that had invaded the left optic nerve, originating from the left posterior ethmoid sinus. Immunohistochemical analyses identified positive staining for NUT protein in the nuclei of tumor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Internal Medicine 2022/04/15, Vol.61(8), pp.1299-1304
Hauptverfasser: Muramatsu, Joji, Takada, Kohichi, Sugita, Shintaro, Tsuchiya, Takaaki, Yamamoto, Keisuke, Takagi, Masaru, Murase, Kazuyuki, Ameda, Saki, Arihara, Yohei, Miyanishi, Koji, Sakata, Koh-Ichi, Kato, Junji
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1304
container_issue 8
container_start_page 1299
container_title Internal Medicine
container_volume 61
creator Muramatsu, Joji
Takada, Kohichi
Sugita, Shintaro
Tsuchiya, Takaaki
Yamamoto, Keisuke
Takagi, Masaru
Murase, Kazuyuki
Ameda, Saki
Arihara, Yohei
Miyanishi, Koji
Sakata, Koh-Ichi
Kato, Junji
description An 18-year-old man presented with sudden vision loss in his left eye. Magnetic resonance imaging revealed a tumor that had invaded the left optic nerve, originating from the left posterior ethmoid sinus. Immunohistochemical analyses identified positive staining for NUT protein in the nuclei of tumor cells. We diagnosed locally advanced NUT carcinoma (NC) and initiated concurrent chemoradiotherapy (CCRT), consisting of chemotherapy with vincristine, doxorubicin, and cyclophosphamide, alternating with ifosphamide and etoposide, plus radiation therapy. The patient achieved a complete response. CCRT can be a useful treatment option for adolescent and young-adult patients with locally advanced unresectable NC.
doi_str_mv 10.2169/internalmedicine.7741-21
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9107965</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2580026750</sourcerecordid><originalsourceid>FETCH-LOGICAL-c609t-e6660ab9bd19ebf5c99d314cd0148cb3ea114cf57df361f386a0b425f75e436f3</originalsourceid><addsrcrecordid>eNplkUFr3DAQhUVpabZJ_0IR9NKLU8myZetSKCZNAiEpITn0JGR5HGuxJVeSW_bfV2a3S5tcRoj3zdNoHkKYkvOccvHZ2AjeqnGCzmhj4byqCprl9BXaUFaIrMpZ-RptiKB1lqdygt6FsCWE1ZXI36ITVnBa1jnZoB-Nm-YRIuB7CLOzAfC17RYNHW53uHFWL96DjbgZYHJedcbFAbyad9hYrPB3Fc0q_zZxwLePD7hRPk3kJnWG3vRqDPD-cJ6ix28XD81VdnN3ed18vck0JyJmwDknqhVtRwW0famF6BgtdEdoUeuWgaLp1pdV1zNOe1ZzRdoiL_uqhILxnp2iL3vfeWnTPnSaxqtRzt5Myu-kU0b-r1gzyCf3SwpKKsHLZPDpYODdzwVClJMJGsZRWXBLkHlZE5LzqiQJ_fgM3bplDSJRPC1UcFqvVL2ntHcheOiPw1Ai1_zk8_zkml-SUuuHfz9zbPwbWAJu98A2RPUER0D5aPQIL505lfVaDi8cQT0oL8GyPxmGun8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2658296180</pqid></control><display><type>article</type><title>Complete Response Induced by Concurrent Chemoradiotherapy in a Patient with NUT Carcinoma</title><source>J-STAGE Free</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Muramatsu, Joji ; Takada, Kohichi ; Sugita, Shintaro ; Tsuchiya, Takaaki ; Yamamoto, Keisuke ; Takagi, Masaru ; Murase, Kazuyuki ; Ameda, Saki ; Arihara, Yohei ; Miyanishi, Koji ; Sakata, Koh-Ichi ; Kato, Junji</creator><creatorcontrib>Muramatsu, Joji ; Takada, Kohichi ; Sugita, Shintaro ; Tsuchiya, Takaaki ; Yamamoto, Keisuke ; Takagi, Masaru ; Murase, Kazuyuki ; Ameda, Saki ; Arihara, Yohei ; Miyanishi, Koji ; Sakata, Koh-Ichi ; Kato, Junji</creatorcontrib><description>An 18-year-old man presented with sudden vision loss in his left eye. Magnetic resonance imaging revealed a tumor that had invaded the left optic nerve, originating from the left posterior ethmoid sinus. Immunohistochemical analyses identified positive staining for NUT protein in the nuclei of tumor cells. We diagnosed locally advanced NUT carcinoma (NC) and initiated concurrent chemoradiotherapy (CCRT), consisting of chemotherapy with vincristine, doxorubicin, and cyclophosphamide, alternating with ifosphamide and etoposide, plus radiation therapy. The patient achieved a complete response. CCRT can be a useful treatment option for adolescent and young-adult patients with locally advanced unresectable NC.</description><identifier>ISSN: 0918-2918</identifier><identifier>EISSN: 1349-7235</identifier><identifier>DOI: 10.2169/internalmedicine.7741-21</identifier><identifier>PMID: 34615820</identifier><language>eng</language><publisher>Japan: The Japanese Society of Internal Medicine</publisher><subject>Case Report ; Chemoradiotherapy ; Chemotherapy ; concurrent chemoradiotherapy ; Cyclophosphamide ; Doxorubicin ; Etoposide ; Internal medicine ; Magnetic resonance imaging ; NUT carcinoma ; Optic nerve ; Patients ; Radiation therapy ; Tumor cells ; VDC-IE regimen ; Vincristine</subject><ispartof>Internal Medicine, 2022/04/15, Vol.61(8), pp.1299-1304</ispartof><rights>2022 by The Japanese Society of Internal Medicine</rights><rights>Copyright Japan Science and Technology Agency 2022</rights><rights>Copyright © 2022 by The Japanese Society of Internal Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c609t-e6660ab9bd19ebf5c99d314cd0148cb3ea114cf57df361f386a0b425f75e436f3</citedby><cites>FETCH-LOGICAL-c609t-e6660ab9bd19ebf5c99d314cd0148cb3ea114cf57df361f386a0b425f75e436f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107965/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107965/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,1877,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34615820$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Muramatsu, Joji</creatorcontrib><creatorcontrib>Takada, Kohichi</creatorcontrib><creatorcontrib>Sugita, Shintaro</creatorcontrib><creatorcontrib>Tsuchiya, Takaaki</creatorcontrib><creatorcontrib>Yamamoto, Keisuke</creatorcontrib><creatorcontrib>Takagi, Masaru</creatorcontrib><creatorcontrib>Murase, Kazuyuki</creatorcontrib><creatorcontrib>Ameda, Saki</creatorcontrib><creatorcontrib>Arihara, Yohei</creatorcontrib><creatorcontrib>Miyanishi, Koji</creatorcontrib><creatorcontrib>Sakata, Koh-Ichi</creatorcontrib><creatorcontrib>Kato, Junji</creatorcontrib><title>Complete Response Induced by Concurrent Chemoradiotherapy in a Patient with NUT Carcinoma</title><title>Internal Medicine</title><addtitle>Intern. Med.</addtitle><description>An 18-year-old man presented with sudden vision loss in his left eye. Magnetic resonance imaging revealed a tumor that had invaded the left optic nerve, originating from the left posterior ethmoid sinus. Immunohistochemical analyses identified positive staining for NUT protein in the nuclei of tumor cells. We diagnosed locally advanced NUT carcinoma (NC) and initiated concurrent chemoradiotherapy (CCRT), consisting of chemotherapy with vincristine, doxorubicin, and cyclophosphamide, alternating with ifosphamide and etoposide, plus radiation therapy. The patient achieved a complete response. CCRT can be a useful treatment option for adolescent and young-adult patients with locally advanced unresectable NC.</description><subject>Case Report</subject><subject>Chemoradiotherapy</subject><subject>Chemotherapy</subject><subject>concurrent chemoradiotherapy</subject><subject>Cyclophosphamide</subject><subject>Doxorubicin</subject><subject>Etoposide</subject><subject>Internal medicine</subject><subject>Magnetic resonance imaging</subject><subject>NUT carcinoma</subject><subject>Optic nerve</subject><subject>Patients</subject><subject>Radiation therapy</subject><subject>Tumor cells</subject><subject>VDC-IE regimen</subject><subject>Vincristine</subject><issn>0918-2918</issn><issn>1349-7235</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNplkUFr3DAQhUVpabZJ_0IR9NKLU8myZetSKCZNAiEpITn0JGR5HGuxJVeSW_bfV2a3S5tcRoj3zdNoHkKYkvOccvHZ2AjeqnGCzmhj4byqCprl9BXaUFaIrMpZ-RptiKB1lqdygt6FsCWE1ZXI36ITVnBa1jnZoB-Nm-YRIuB7CLOzAfC17RYNHW53uHFWL96DjbgZYHJedcbFAbyad9hYrPB3Fc0q_zZxwLePD7hRPk3kJnWG3vRqDPD-cJ6ix28XD81VdnN3ed18vck0JyJmwDknqhVtRwW0famF6BgtdEdoUeuWgaLp1pdV1zNOe1ZzRdoiL_uqhILxnp2iL3vfeWnTPnSaxqtRzt5Myu-kU0b-r1gzyCf3SwpKKsHLZPDpYODdzwVClJMJGsZRWXBLkHlZE5LzqiQJ_fgM3bplDSJRPC1UcFqvVL2ntHcheOiPw1Ai1_zk8_zkml-SUuuHfz9zbPwbWAJu98A2RPUER0D5aPQIL505lfVaDi8cQT0oL8GyPxmGun8</recordid><startdate>20220415</startdate><enddate>20220415</enddate><creator>Muramatsu, Joji</creator><creator>Takada, Kohichi</creator><creator>Sugita, Shintaro</creator><creator>Tsuchiya, Takaaki</creator><creator>Yamamoto, Keisuke</creator><creator>Takagi, Masaru</creator><creator>Murase, Kazuyuki</creator><creator>Ameda, Saki</creator><creator>Arihara, Yohei</creator><creator>Miyanishi, Koji</creator><creator>Sakata, Koh-Ichi</creator><creator>Kato, Junji</creator><general>The Japanese Society of Internal Medicine</general><general>Japan Science and Technology Agency</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220415</creationdate><title>Complete Response Induced by Concurrent Chemoradiotherapy in a Patient with NUT Carcinoma</title><author>Muramatsu, Joji ; Takada, Kohichi ; Sugita, Shintaro ; Tsuchiya, Takaaki ; Yamamoto, Keisuke ; Takagi, Masaru ; Murase, Kazuyuki ; Ameda, Saki ; Arihara, Yohei ; Miyanishi, Koji ; Sakata, Koh-Ichi ; Kato, Junji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c609t-e6660ab9bd19ebf5c99d314cd0148cb3ea114cf57df361f386a0b425f75e436f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Case Report</topic><topic>Chemoradiotherapy</topic><topic>Chemotherapy</topic><topic>concurrent chemoradiotherapy</topic><topic>Cyclophosphamide</topic><topic>Doxorubicin</topic><topic>Etoposide</topic><topic>Internal medicine</topic><topic>Magnetic resonance imaging</topic><topic>NUT carcinoma</topic><topic>Optic nerve</topic><topic>Patients</topic><topic>Radiation therapy</topic><topic>Tumor cells</topic><topic>VDC-IE regimen</topic><topic>Vincristine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Muramatsu, Joji</creatorcontrib><creatorcontrib>Takada, Kohichi</creatorcontrib><creatorcontrib>Sugita, Shintaro</creatorcontrib><creatorcontrib>Tsuchiya, Takaaki</creatorcontrib><creatorcontrib>Yamamoto, Keisuke</creatorcontrib><creatorcontrib>Takagi, Masaru</creatorcontrib><creatorcontrib>Murase, Kazuyuki</creatorcontrib><creatorcontrib>Ameda, Saki</creatorcontrib><creatorcontrib>Arihara, Yohei</creatorcontrib><creatorcontrib>Miyanishi, Koji</creatorcontrib><creatorcontrib>Sakata, Koh-Ichi</creatorcontrib><creatorcontrib>Kato, Junji</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Internal Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Muramatsu, Joji</au><au>Takada, Kohichi</au><au>Sugita, Shintaro</au><au>Tsuchiya, Takaaki</au><au>Yamamoto, Keisuke</au><au>Takagi, Masaru</au><au>Murase, Kazuyuki</au><au>Ameda, Saki</au><au>Arihara, Yohei</au><au>Miyanishi, Koji</au><au>Sakata, Koh-Ichi</au><au>Kato, Junji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Complete Response Induced by Concurrent Chemoradiotherapy in a Patient with NUT Carcinoma</atitle><jtitle>Internal Medicine</jtitle><addtitle>Intern. Med.</addtitle><date>2022-04-15</date><risdate>2022</risdate><volume>61</volume><issue>8</issue><spage>1299</spage><epage>1304</epage><pages>1299-1304</pages><artnum>7741-21</artnum><issn>0918-2918</issn><eissn>1349-7235</eissn><abstract>An 18-year-old man presented with sudden vision loss in his left eye. Magnetic resonance imaging revealed a tumor that had invaded the left optic nerve, originating from the left posterior ethmoid sinus. Immunohistochemical analyses identified positive staining for NUT protein in the nuclei of tumor cells. We diagnosed locally advanced NUT carcinoma (NC) and initiated concurrent chemoradiotherapy (CCRT), consisting of chemotherapy with vincristine, doxorubicin, and cyclophosphamide, alternating with ifosphamide and etoposide, plus radiation therapy. The patient achieved a complete response. CCRT can be a useful treatment option for adolescent and young-adult patients with locally advanced unresectable NC.</abstract><cop>Japan</cop><pub>The Japanese Society of Internal Medicine</pub><pmid>34615820</pmid><doi>10.2169/internalmedicine.7741-21</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-2918
ispartof Internal Medicine, 2022/04/15, Vol.61(8), pp.1299-1304
issn 0918-2918
1349-7235
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9107965
source J-STAGE Free; PubMed Central; PubMed Central Open Access
subjects Case Report
Chemoradiotherapy
Chemotherapy
concurrent chemoradiotherapy
Cyclophosphamide
Doxorubicin
Etoposide
Internal medicine
Magnetic resonance imaging
NUT carcinoma
Optic nerve
Patients
Radiation therapy
Tumor cells
VDC-IE regimen
Vincristine
title Complete Response Induced by Concurrent Chemoradiotherapy in a Patient with NUT Carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T08%3A55%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Complete%20Response%20Induced%20by%20Concurrent%20Chemoradiotherapy%20in%20a%20Patient%20with%20NUT%20Carcinoma&rft.jtitle=Internal%20Medicine&rft.au=Muramatsu,%20Joji&rft.date=2022-04-15&rft.volume=61&rft.issue=8&rft.spage=1299&rft.epage=1304&rft.pages=1299-1304&rft.artnum=7741-21&rft.issn=0918-2918&rft.eissn=1349-7235&rft_id=info:doi/10.2169/internalmedicine.7741-21&rft_dat=%3Cproquest_pubme%3E2580026750%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2658296180&rft_id=info:pmid/34615820&rfr_iscdi=true